[Commentary] On July 8, the State Council Information Office held a regular policy briefing of the State Council to introduce the key tasks of deepening the reform of the medical and health system in 2021. Wang Guodong, head of the Medical Price and Bidding and Purchasing Department of the National Medical Security Administration, introduced the promotion of drugs Since the reform of centralized procurement of consumables, five batches of centralized procurement have been completed, involving a total of 218 varieties. Based on the agreed procurement volume, it is estimated that the annual drug cost can be saved by 92.6 billion yuan.
[Explanation] Centralized procurement with volume is an important part of deepening the reform of the medical and health system. In accordance with the basic principle of "integration of recruitment and procurement, linked volume and price", the fifth batch of centralized procurement has announced the results at the end of June and is expected to be October this year. Patients can use the fifth batch of centralized procurement drugs.
[Concurrent] Wang Guodong, Head of the Department of Medical Price and Bidding and Purchasing, National Medical Security Administration
Everyone knows that this centralized procurement is the largest ever, involving 55 billion yuan in purchases from public hospitals, and 61 varieties were selected, all of which set the highest ever.
[Explanation] The fifth batch of centralized procurement pays more attention to the guarantee of product supply, and introduces the terms of alternative companies; at the same time, the company’s compliance with pharmaceutical prices and the recruitment and procurement credit evaluation system is taken into consideration.
In the fifth batch of centralized procurement, injections have become the main dosage form, marking that centralized procurement is moving towards the core area of falsely high drug prices.
[Concurrent] Wang Guodong, Head of the Department of Medical Price and Bidding and Purchasing, National Medical Security Administration
Injections have become the main dosage form of centralized procurement, and you may have seen it. We successfully selected 31 injection varieties this time, accounting for half of all the selected varieties, and the amount accounted for 70%. It is also the previous four batches of our centralized procurement injection varieties. (Total number) is more than twice, this is a relatively obvious feature, and the price drop of injections is higher than the 56% average drop of this fifth batch of centralized procurement, which also marks the core of our centralized procurement direction (increase in drug prices) The zone has taken an important step.
[Explanation] The data shows that the fifth batch of centralized procurement has the largest drop, with drug prices dropping by 98%, and patients will become the biggest beneficiaries.
[Concurrent] Wang Guodong, Head of the Department of Medical Price and Bidding and Purchasing, National Medical Security Administration
From the perspective of five batches of centralized procurement, a total of 218 varieties are involved. These 218 varieties are calculated based on the prices before the centralized procurement and account for 30% of the purchase amount of chemical drugs from public medical institutions.
Counting this centralized procurement, we expect to save 92.6 billion yuan in drug costs (yearly).
[Explanation] Wang Guodong said that in the future, more varieties will be included in the collection, so that this reform can benefit more people.
At the same time, medical institutions are encouraged to strengthen internal management and improve the level of clinical drug management, so that this reform can truly benefit patients, enterprises and medical institutions.
Reporter Jean Baokui reports from Beijing
Editor in charge: [Wang Kai]